Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-08 @ 8:45 PM
Study NCT ID:
NCT01406327
Status:
COMPLETED
Last Update Posted:
2020-09-03
First Post:
2011-07-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-28
First Submit QC Date:
None
Study First Post Date:
2011-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-02
Last Update Post Date:
2020-09-03
Last Update Post Date Type:
ACTUAL